Your browser doesn't support javascript.
loading
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells.
Ruella, Marco; Barrett, David M; Shestova, Olga; Perazzelli, Jessica; Posey, Avery D; Hong, Seok Jae; Kozlowski, Miroslaw; Lacey, Simon F; Melenhorst, J Joseph; June, Carl H; Gill, Saar I.
Afiliação
  • Ruella M; Center for Cellular Immunotherapies and.
  • Barrett DM; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Shestova O; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Perazzelli J; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA.
  • Posey AD; Center for Cellular Immunotherapies and.
  • Hong SJ; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA.
  • Kozlowski M; Center for Cellular Immunotherapies and.
  • Lacey SF; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Melenhorst JJ; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA.
  • June CH; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA; and.
  • Gill SI; Center for Cellular Immunotherapies and.
Blood ; 135(7): 505-509, 2020 02 13.
Article em En | MEDLINE | ID: mdl-31703119

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Antígenos CD19 / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Antígenos CD19 / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article